Brief: Armata Pharmaceuticals Board Appoints Julianne Averill As Chief Financial Officer
05/05/2023 22:48
May 5 (Reuters) - Armata Pharmaceuticals Inc ARMP.A :
* ARMATA PHARMACEUTICALS - ON MAY 4, CO'S BOARD APPOINTED
JULIANNE
AVERILL TO SERVE, EFFECTIVE AS OF MAY 2, 2023, AS CHIEF
FINANCIAL OFFICER
* ARMATA PHARMACEUTICALS - AVERILL TO ALSO SERVE AS
PRINCIPAL
FINANCIAL OFFICER AND PRINCIPAL ACCOUNTING OFFICER OF CO
Source: (https://shorturl.at/nzJQS)
Further company coverage: ARMP.A
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Armata Pharmaceuticals
See all newsBrief: Armata Pharmaceuticals Announces First Quarter 2026 Results And Provides Corporate Update
Brief: Armata Pharmaceuticals Delays Announcement Of Fourth Quarter And Full-Year 2025 Results And Provides Corporate Update
Brief: Armata Pharmaceuticals Receives FDA Qualified Infectious Disease Product Designation
Armata Pharma jumps on US FDA nod for late-stage infection trial
Brief: Armata Pharmaceuticals Commissions cGMP Manufacturing Facility In Los Angeles